Seer Board Unanimously Rejects Radoff-JEC's $2.40/Share Acquisition Offer, Reiterates Standalone Strategy

summarizeSummary

Seer's Board of Directors has unanimously rejected the Radoff-JEC Group's latest unsolicited acquisition proposal of $2.40 per share, reaffirming its commitment to operating as a standalone company despite ongoing financial challenges.

check_boxKey Events

• Board Rejects Acquisition Offer

  Seer's Board of Directors unanimously rejected the Radoff-JEC Group's revised non-binding proposal to acquire all outstanding shares for $2.40 per share.

• Reiteration of Standalone Strategy

  The Board and management expressed high confidence in their go-forward strategy as a standalone company, urging employees to remain focused on business priorities.

• Ongoing Activist Battle

  This rejection follows a series of proposals from the Radoff-JEC Group, who increased their stake to 7.6% and previously offered $2.25 and $2.35 per share, all of which were rejected by Seer's Board. This decision comes after Seer adopted a poison pill in February 2026.

• Premium to Current Price

  The rejected offer of $2.40 per share represents a significant premium over the current stock price of $1.83, indicating the Board's belief in higher intrinsic value.

auto_awesomeAnalysis

Seer's Board has once again unanimously rejected a premium acquisition offer from activist investor Radoff-JEC Group, opting to pursue its standalone strategy despite a 34% revenue decline and increased cash burn reported in Q1 2026. The rejected offer of $2.40 per share is substantially above the current market price of $1.83, indicating the Board believes the company's long-term value exceeds this offer. This decision prolongs the activist battle and removes a potential near-term exit for shareholders at a premium, placing increased pressure on management to deliver on its independent strategy.